Key points are not available for this paper at this time.
The dashed horizontal line represents the Danish patent expiration of the brand-name adalimumab on October 16, 2018. The patent expiration was immediately followed by a shift to biosimilars with a substantial cost reduction.
Building similarity graph...
Analyzing shared references across papers
Loading...
Thomas Bo Jensen
Seoyoung C. Kim
Espen Jimenez‐Solem
JAMA Internal Medicine
Brigham and Women's Hospital
Copenhagen University Hospital
Bispebjerg Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Jensen et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69df6e40d5404a0bea59316d — DOI: https://doi.org/10.1001/jamainternmed.2020.0338